Cover story - advertising feature
with incompatible materials and substances can damage various probe components,3 leading to expensive repairs or replacements – as well as ineffective HLD.
The use of effective high-level chemistry is proven in real clinical settings to get into complex shapes, cracks, and cavities. Trophon® technology uses vibration and nebulised hydrogen peroxide vapour to create droplets of mist so small, it can get into all surfaces of the suspended probe; every crevice and imperfection caused by clinical use, delivering HLD to every area of the probe. Trophon® technology uses Hydrogen
Peroxide (H2 O2 ) a naturally occurring chemistry
that is found in the environment and within the human body: l In the human body, hydrogen peroxide is produced primarily in three places: lung, gut, and thyroid gland.
l Commensal lactobacilli in the vagina produces hydrogen peroxide that plays an antibacterial role by preventing growth of bacterial species associated with bacterial vaginosis.
Great power comes with great responsibility.
l Immune cells, such as white blood cells, use hydrogen peroxide as a defence mechanism against pathogens.
l In our surrounding environment, hydrogen peroxide is use in first aid, oral care, household cleaning, laundry, hair care, spa and beauty treatments, pool and hot tub maintenance, and plant care.
But it’s deadly for organisms, meaning effective, efficient HLD. Once each cycle of HLD has been carried out with trophon® , H2
O2 The trophon® is discarded
in the form of oxygen and water – making it a clean and sustainable way to ensure HLD.
The importance of material compatibility To ensure the efficacy of HLD, verification that the method is compatible with the probe and the materials it comprises is vitally important. It’s important in the prevention of damage to probes, and ensuring effective HLD. The gold standard in ensuring this fact - is rigorous compatibility testing. Nanosonics’ extensive compatibility programme is carried out collaboratively with market-leading probe manufacturers – with now over 1,300 ultrasound probes across 26 manufacturers approved as compatible for use. The tests rigorously assess long-term effects of trophon’s ‘sonically activated’ hydrogen peroxide (H2
O2
probe, ensuring no damage is caused to the sensitive probe surface.
uses the powerful chemistry of hydrogen peroxide (H202), which is deadly for pathogens. But once the disinfection process is finished, trophon®
2 device is the only automated high-level disinfection (HLD) that technology
Conclusion Careful consideration should be paid to selecting the right method of HLD, which will not only help
breaks down the H202 into oxygen and water – which are safer for you, your patients, your equipment and the environment. That’s why it’s a power in HLD.
To learn more, visit
nanosonics.co.uk
‘sonically-activated’ hydrogen peroxide. Nanosonics and trophon are trade marks of Nanosonics Limited. © 2024 Nanosonics Limited. All rights reserved. 2079023-UK-AD. December 2024.
Nanosonics UK Limited. Ground Floor at The Forum, Unit C1 & C2, Hercules Business Park, Bird Hall Lane, Stockport, SK3 0UX, UK. T: +44 (0) 161 686 3030 E:
info@nanosonics.co.uk W:
www.nanosonics.co.uk The trophon®
family includes the trophon® EPR and trophon® 2 devices which share the same core technology of
Nanosonics UK Limited. Ground Floor at The Forum, Unit C1 & C2, Hercules Business Park, Bird Hall Lane, Stockport, SK3 0UX, UK. T: +44 (0) 161 686 3030 E:
info@nanosonics.co.uk W:
www.nanosonics.co.uk
The trophon® family includes the trophon® EPR and trophon®2 devices which share the same core technology of ‘sonically-activated’ hydrogen peroxide. Nanosonics and trophon are trade marks of Nanosonics Limited. © 2024 Nanosonics Limited. All rights reserved. 2141714-UK-AD.
April 2025 I
www.clinicalservicesjournal.com 59
to better protect your equipment and teams, but most importantly – your patients. Alongside the considerations listed above, trophon® technology presents itself as the world’s leading HLD solution for ultrasound probes by offering additional features of traceability, optimised workflows, support and service packages, and a full portfolio of accessories to support best practice. If you’d like to find out more, visit
www.nanosonics.co.uk
References 1. Dudley NJ, Woolley DJ. A multicentre survey of the condition of ultrasound probes. Ultrasound. 2016;24(4):190-7
) mist, on each
2. Martensson M, et al. High incidence of defective ultrasound transducers in use in routine clinical practice. Eur J Echocardiogr. 2009; 10(3):389-94.
3. Bigelow TA et al. Ensuring clinical efficacy and patient safety with repaired ultrasound probes. J Ultrasound Med. 2018; 37:315-328.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100
